IVD packaging market seen reaching $14.51 billion by 2030

The Business Research Company says the global in vitro diagnostic packaging market is growing as demand rises for sterile, contamination-resistant materials that protect diagnostic kits and samples. The market is projected to climb from $10.82 billion in 2026 to $14.51 billion by 2030, led by North America now and Asia-Pacific expected to grow fastest.

Why it matters: - In vitro diagnostic packaging helps protect test kits and samples from contamination, damage and environmental exposure. - Demand is rising as diagnostic testing becomes more central to disease detection, monitoring and treatment. - The market outlook points to steady growth for suppliers tied to healthcare infrastructure, laboratory testing and supply-chain safety.

What happened: - The Business Research Company released its Global Market Report 2026 on in vitro diagnostic packaging. - The report puts the market at $10.82 billion in 2026, up from $10.04 billion in 2025. - The report forecasts the market will reach $14.51 billion by 2030. - The forecast implies a 7.6% CAGR from 2026 to 2030.

The details: - The historical growth rate from 2025 to 2026 was 7.8%. - The report links recent growth to wider use of in vitro diagnostic testing, more clinical laboratory infrastructure, stronger demand for accurate diagnosis, higher global healthcare spending and advanced packaging materials. - Looking ahead, the report points to growth drivers including point-of-care diagnostic technologies, eco-friendly medical packaging, molecular diagnostics, healthcare infrastructure investment and tighter focus on safety and integrity in supply chains. - Expected trends include more demand for sterile and contamination-resistant packaging, wider use of tamper-evident solutions, more high-barrier plastics and glass, expanded custom packaging for diagnostic kits and stricter regulatory compliance. - The report defines in vitro diagnostic packaging as specialized containers and materials used to store and transport IVD devices safely. - IVD devices test biological samples such as blood or tissue to detect disease or monitor health conditions. - The packaging is designed to help preserve test reliability and accuracy by shielding products from contamination, physical damage and environmental influences. - The report includes new strategic additions for 2026 such as market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis and updated graphics and tables. - Download a free sample of the report. - View the full market report.

Between the lines: - Rising chronic disease and infection rates are increasing the need for secure diagnostic testing and the packaging that supports it. - The report cites UK Health Security Agency data showing measles cases in England rose to 368 in 2023 from 53 in 2022. - The West Midlands accounted for 44% of those cases and London for 33%. - North America was the largest regional market in 2025 because of its advanced healthcare infrastructure and high diagnostic demand. - Asia-Pacific is projected to be the fastest-growing regional market as healthcare facilities expand and investment in diagnostics increases. - The report also tracks South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

What's next: - Market growth is expected to continue through 2030 as point-of-care testing and molecular diagnostics expand. - Packaging suppliers may face more pressure to deliver sterile, tamper-evident and regulation-ready products. - Eco-friendly materials are likely to gain more attention as medical packaging standards evolve.

The bottom line: - The IVD packaging market is moving from steady demand to broader strategic importance as diagnostic testing, regulation and supply-chain protection converge.